Synthetic cannabinoids JWH-018 and JWH-073 acted like THC in monkeys but wore off faster | Research

The takeaway

In monkeys trained to recognize THC, synthetic cannabinoids JWH-018 and JWH-073 produced identical subjective effects but lasted only 1-2 hours compared to THC's 4 hours, potentially increasing dependence risk.

Read this if you want to understand why synthetic cannabinoids ("Spice/K2") may be more addictive than natural cannabis.

JWH-018 was 3x more potent than THC but lasted only half as long

What the researchers found

Researchers tested JWH-018 and JWH-073 (common synthetic cannabinoids in "Spice" and "K2" products) in monkeys trained to discriminate THC from placebo. Both synthetics fully substituted for THC, confirming they produce the same subjective effects through CB1 receptors.

JWH-018 was about 3 times more potent than THC (ED50: 0.013 vs 0.044 mg/kg). JWH-073 was roughly equipotent. Critically, the duration of action was much shorter: JWH-018 lasted about 2 hours and JWH-073 about 1 hour, compared to THC's 4 hours.

Both synthetics also attenuated THC withdrawal in dependent monkeys, confirming pharmacological interchangeability. The shorter duration could promote more frequent dosing, increasing the number of drug-reward pairings and potentially accelerating dependence.

Why it matters

This study explained why synthetic cannabinoids may be more addictive than natural cannabis: they produce the same high but wear off faster, encouraging more frequent use. More frequent dosing strengthens the habit loop.

The numbers in context

JWH-018 ED50: 0.013 mg/kg (3x more potent than THC). JWH-073 ED50: 0.058 mg/kg. Duration: JWH-018 ~2 hrs, JWH-073 ~1 hr, THC ~4 hrs. All reversed by CB1 antagonist rimonabant.

How the study worked

Drug discrimination study in rhesus monkeys (n=4) trained to discriminate THC. Additionally tested in monkeys (n=3) trained to discriminate rimonabant (withdrawal) during chronic THC treatment. Dose-response curves, antagonism studies, and duration assessments were conducted.

What this study cannot tell us

Small number of monkeys (3-4). Drug discrimination measures subjective effects, not all aspects of abuse liability. Only two synthetic cannabinoids were tested from hundreds that exist. Laboratory setting does not capture real-world use patterns.

How to read the evidence

Primate drug discrimination study with rigorous pharmacological methods. Small sample but highly controlled conditions.

When this study was published

Published in 2012. The synthetic cannabinoid landscape has changed dramatically, with hundreds of new compounds since.

The bigger picture

This was important pharmacological groundwork for understanding the "Spice/K2" epidemic. The finding that higher potency plus shorter duration equals greater dependence risk had direct public health implications.

Questions still open

Do all synthetic cannabinoids share this short-duration profile? Would longer-acting synthetics have less abuse liability? Can these findings inform scheduling decisions for emerging synthetic cannabinoids?

Common questions

Are synthetic cannabinoids more addictive than THC?

This study found JWH-018 was more potent and wore off faster than THC. Shorter duration of action promotes more frequent use, which strengthens drug-seeking habits. Combined with higher potency, this creates a pharmacological profile consistent with greater dependence risk.

Do synthetic cannabinoids work the same way as THC?

Yes, in this study they activated the same CB1 receptors and produced identical subjective effects in monkeys trained to recognize THC. They also relieved THC withdrawal, confirming they act through the same system.

Read the original research

JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.

The Journal of pharmacology and experimental therapeutics, 340(1), 37-45

View on PubMed ↗Publisher’s paper ↗

Citation

Ginsburg, Brett C; Schulze, David R; Hruba, Lenka; McMahon, Lance R. (2012). JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.. The Journal of pharmacology and experimental therapeutics, 340(1), 37-45. https://doi.org/10.1124/jpet.111.187757